Venture Capital/News/

France’s Eurazeo announces €1.6bn growth fund

The French asset manager’s growth team has backed European unicorns such as Doctolib and Glovo.

By Eleanor Warnock

Credit: Yann du Rusquec, partner at Eurazeo Growth and Benoist Grossmann, CEO Eurazeo Investment Manager and managing partner, venture and growth.

French investment group Eurazeo has closed a new growth fund worth more than €1.6bn, another indication of the growing strength and maturity of Europe’s growth equity market. 

The fund is Eurazeo’s third growth vehicle since the firm started a growth strategy in 2014. The growth team invests in companies from Series C onwards with initial investments of €25-100m and the potential for follow on. Most of the investments are in Europe in the areas of B2B SaaS, digital health, cybersecurity, infrastructure software, fintech and marketplaces. 

The firm’s €1bn growth portfolio includes European unicorns such as digital healthtech Doctolib and Spanish delivery company Glovo

As Europe creates more tech successes such as Adyen and Spotify, experienced founders and operators are aiming to stay private longer as they grow their business, fueling demand for investors who can keep plugging capital into their businesses at the later stages. Europe has seen some large growth funds recently including Index’s $2bn fund announced yesterday, which it will use to invest in businesses all the way up to IPO. 

“Instead of trying to find a way to exit, find a buyer or reach profitability, [European tech companies] are deciding to raise more money from investors to invest more in the business, grow, launch new products and grow in new geographies. Not all of them want to be global but all of them want to be a very big business in a vast territory,” says Yann du Rusquec, partner at Eurazeo Growth. 

“There has clearly been a change in the ambition of entrepreneurs.”

He added that the firm had already deployed more than half of the fund.

Eurazeo is one of a small group of publicly-traded European private equity and VC firms that includes Bridgepoint, EQT, Partners Group, Forward Partners and Draper Esprit. The company manages €15bn in private equity assets across buyout, venture and growth strategies. 

Next steps for European growth equity 

The Eurazeo growth team has already seen several high profile exits, including Farfetch; it sold all of its shares in the online fashion marketplace in 2020, netting €90.4m, equal to 4.1x return cash-on-cash on the original investment. 

Another Eurazeo growth portfolio company, Swedish fintech Tink, announced an agreement for €1.8bn acquisition by Visa in June, just a half year after Eurazeo had invested. If completed, the deal would be the third-largest acquisition of a European VC-backed fintech. 

Du Rusquec says that European “growth equity is not a mature market” and that more exits and IPOs from European startups will help take the continent’s growth equity to the next level, on par with the US. 

There is already a strong pipeline of European tech companies looking to list, though many successful European tech companies have chosen to list in the US, such as UK-based healthtech giant Babylon (via a SPAC) and UiPath. Du Rusquec says that investors need to tempt European companies with strong European footprints to go public in the region. 

“When they have the choice [between the US or Europe], we just need to convince them that they will get the same valuation and the same high-quality investors by being listed in Europe. That’s what we have to build in the coming years,” he says. 

Government support for Europe’s tech ecosystem 

Du Rusquec and Benoist Grossmann, managing partner for venture and growth, say they’re also grateful for governments and public funds supportive of the region’s ecosystem, including France

“We are extremely lucky to have a government which has given us a lot of tailwinds,” says Grossmann, who is also chairman of France Digitale, which represents the nation’s entrepreneurs and VCs. 

LPs in Eurazeo’s most recent growth fund include public capital from the European Investment Fund, British Patient Capital and France’s public investment arm Bpifrance

European policymakers have “realised that we have to build a tech economy otherwise it’s going to be very hard for us to compete at a global level and make ourselves understood by the largest tech companies in the US and Asia,” says Du Rusquec. 

Join the conversation

avatar
  Subscribe  
Notify of